Vaxart (VXRT) Stock Is Moving Towards Bullish Behavior With 10% Gain

Vaxart Inc. (VXRT) gained after-hours following the release of positive results from a study that showed its oral tablet vaccine reduced the spread of SARS-CoV-2 in an animal model. VXRT stock surges over 9% in the pre-market session. It is trading at $7.77 today. Vaxart said that the results of its Phase 2 human flu challenge study are consistent with those from its Phase 2 study, which showed that its oral tablet vaccine was better than the injectable flu vaccine.
Vaxart said that its oral vaccine platform has the potential to trigger a broad and robust mucosal response in humans. The results of the study indicate that Vaxart’s oral vaccine could provide better protection against respiratory viruses than conventional vaccines. Vaxart is a biotechnology company focused on the development of vaccines for the protection of people against various infectious diseases. Vaxart has traded between $24.90 and $7.87 over the past 52 weeks. In late-hours trading on Thursday, the stock gained 11%.

Anthony Gonzales

Biotech, Tech, and Crypto reporterAnthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.